Drug points: Sibutramine may be associated with memory impairment

British Medical Journal

Volumn 329, Issue 7478, 2004, Pages 1316-

  Clark, David W J ^a,b   Harrison Woolrych, Mira ^a,b,c  

^a Intensive Medicines Monitoring Programme (IMMP)   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c NONE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; ANOREXIGENIC AGENT; CYCLOBUTANE DERIVATIVE;

ADULT; AMNESIA; CASE REPORT; CEREBROVASCULAR DISEASE; CONFUSION; DISEASE ASSOCIATION; DIZZINESS; DRUG WITHDRAWAL; DYSARTHRIA; FEMALE; HEADACHE; HUMAN; MEMORY DISORDER; MIGRAINE; NECK INJURY; OBESITY; PRIORITY JOURNAL; SHORT SURVEY; STIFF NECK; VISUAL DISORDER; ARTICLE; CHEMICALLY INDUCED DISORDER;

ADULT; APPETITE DEPRESSANTS; CYCLOBUTANES; FEMALE; HUMANS; MEMORY DISORDERS;

EID: 14944365566     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. Buhot MC, Martin S, Segu L. Role of serotonin in memory impairment. Ann Med 2000;32:210-21.
2. Joss JD, Burton RM, Keller CA. Memory loss in a patient treated with fluoxetine. Ann Pharmacother 2003;37:1800-3.
3. Physicians Desk Reference (online). www.pdr.aer/ (accessed 18 Nov 2004).